IP Library Patent Application 18102031
Patent Application
App. No. 18/102,031

NUCLEIC ACID AMPLIFICATION PROCESSES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/102,031
Abstract

Disclosed is a method of performing a non-isothermal nucleic acid amplification reaction, the method comprising the steps of: (a) mixing a target sequence with one or more complementary single stranded primers in conditions which permit a hybridisation event in which the primers hybridise to the target, which hybridisation event, directly or indirectly, leads to the formation of a duplex structure comprising two nicking sites disposed at or near opposite ends of the duplex; and performing an amplification process by; (b) causing a nick at each of said nicking sites in the strands of the duplex; (c) using a polymerase to extend the nicked strands so as to form newly synthesised nucleic acid, which extension with the polymerase recreates nicking sites; (d) repeating steps (b) and (c) as desired so as to cause the production of multiple copies of the newly synthesised nucleic acid; characterised in that the temperature at which the method is performed is non-isothermal, and subject to a reduction of at least 2° C. during the amplification process of steps (b)-(d).

Claims (27)

1 . A method of performing a non-isothermal nucleic acid amplification method comprising:

(a) incubating a reaction mixture comprising a target nucleic acid and one or more complementary single stranded primers at a first temperature, T 1 , which permits a hybridisation event in which the one or more primers hybridize to the target, which hybridisation event, directly or indirectly, leads to the formation of a duplex structure comprising two nicking sites disposed at or near opposite ends of the duplex;

(b) cooling the temperature of the reaction mixture to a second temperature, T 2 , which is at least 2° C. lower than T 1 ;

(c) using a nicking enzyme to cause a nick at each of said nicking sites in the strands of the duplex;

(d) using a polymerase to extend the nicked strands so as to form newly synthesized nucleic acid, which extension with the polymerase creates nicking sites;

(e) repeating steps (c) and (d) so as to cause the production of multiple copies of the newly synthesized nucleic acid;

wherein after step (b), the temperature does not return to the first temperature.

2 .- 31 . (canceled)

32 . The method of claim 1 , wherein the cooling is by application of active cooling to the reaction mix.

33 . The method of claim 1 , wherein the cooling is achieved by passive means.

34 . The method of claim 1 , wherein the cooling is achieved by a combination of active and passive means.

35 . The method of claim 1 , wherein the reaction mix is cooled during step (b) by at least 15° C.

36 . The method of claim 1 , wherein the temperature T 1 in step (a) is in the range 55-62° C.

37 . The method of claim 1 , wherein steps (b)-(e) are performed substantially immediately after step (a), and wherein steps (a)-(e) are performed in the same reaction vessel or on the same solid support.

38 . The method of claim 1 , wherein step (c) is initiated by formation of the duplex structure which comprises two nicking sites disposed at or near opposite ends of the duplex.

39 . The method of claim 1 , further comprising a step of contacting a mixture obtained by performance of the method with a thermolabile enzyme which degrades nucleic acids, the mixture being contacted with the thermolabile enzyme at a temperature at which the thermolabile enzyme is substantially active.

40 . The method of claim 1 , further comprising a step of directly or indirectly detecting the newly synthesized nucleic acid.

41 . The method of claim 1 , wherein step (e) is performed while further cooling the reaction mix.

42 . The method of claim 41 , wherein the reaction mix is cooled during step (b) and/or step (e) by at least 15° C.

43 . The method of claim 41 , wherein the cooling is by application of active cooling to the reaction mix.

44 . The method of claim 41 , wherein the cooling is achieved by passive means.

45 . The method of claim 41 , wherein the cooling is achieved by a combination of active and passive means.

46 . The method of claim 41 , wherein the temperature T 1 in step (a) is in the range 55-62° C.

47 . The method of claim 41 , wherein steps (b)-(e) are performed substantially immediately after step (a), and wherein steps (a)-(e) are performed in the same reaction vessel or on the same solid support.

48 . The method of claim 41 , comprising use of a first polymerase and/or a first nicking enzyme having an optimum temperature, and a second polymerase and/or a second nicking enzyme having an optimum temperature, wherein the optimum temperature of the second polymerase and/or second nicking enzyme is lower than the optimum temperature of the respective first polymerase and/or first nicking enzyme.

49 . The method of claim 41 , further comprising the step of contacting a mixture obtained by performance of the method with a thermolabile enzyme which degrades nucleic acid, the mixture being contacted with the thermolabile enzyme at a temperature at which the thermolabile enzyme is substantially active.

50 . The method of claim 41 , further comprising a step of directly or indirectly detecting the newly synthesized nucleic acid.

Assignments (2)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY, RECORDED ON MARCH 30, 2021 AT REEL/FRAME 055850/0771 Recorded Aug 5, 2024
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: LUMIRADX INTERNATIONAL LTD; LUMIRADX UK LTD
Reel/Frame 068327/0149 →
SECURITY INTEREST Recorded Aug 25, 2023
From: LUMIRADX INTERNATIONAL LTD; LUMIRADX UK LTD
To: BIOPHARMA CREDIT PLC
Reel/Frame 064709/0226 →